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1 
CHAPTER I 
 
GENERAL INTRODUCTION  
 
ANANDAMIDE AND ITS ANALOGUE, OLEOYLETHANOLAMIDE: 
In December 1992 Devane and his collaborators (Devane et al., 1992) reported 
the isolation and structure elucidation of a porcine brain lipid component that se-
lectively displaced the binding of a high-affinity cannabinoid receptor ligand to 
brain membrane preparations. This compound was the ethanolamide of arachi-
donic acid (20:4, n-6) and was named anandamide (AEA) (Figure 1), after the 
Sanskrit word for “bliss”, ananda. AEA was shown to be active in the tetrade of 
mouse behavioral tests suggestive of cannabinoid-like activity, i.e. inhibition of 
locomotor and rearing activity, hypothermy, catalepsy, and analgesia (Fride and 
Mechoulam, 1993; Crawley et al., 1993). Another derivative of arachidonic acid 
that activates cannabinoid receptors, 2-arachidonoylglycerol (2-AG), was discov-
ered in 1995 (Mechoulam et al., 1995; Sugiura et al., 1995). Although structurally 
different from plant-derived cannabinoids, these compounds, in analogy with the 
“endorphins” (i.e. the endogenous ligands of opiate receptors), were named “en-
docannabinoids”.  
Additional natural fatty acid ethanolamides (FAEs) have been detected in virtu-
ally all mammalian cells, tissues and certain body fluids (Bachur et al., 1965; Na-
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tarajan et al., 1985). They have also been identified in fish, invertebrates (Bi-
sogno et al., 1997; Sepe et al., 1998), plants (Chapman et al., 2000) and some mi-
croorganisms (Clarke et al., 1976; Ellingson, 1980). In most mammalian cells and 
tissues FAEs consist primarly of saturated and monounsaturated species, such as 
palmitoylethanolamide (PEA), oleoylethanolamide (OEA), and stearoylethanola-
mide (SEA) (Figure 1). AEA is generally a minor component of cellular FAEs, 
with some exceptions, such as in the periimplantation mouse uterus (Schmid et 
al., 1997).  
It has been shown that FAEs are synthesized in response to a variety of physio-
logical and pathological stimuli, including activation of neurotransmitter recep-
tors in rat brain neurons (Di Marzo et al., 1994; Giuffrida et al., 1999), and expo-
sure to metabolic stressors in mouse epidermal cells (Berdyshev et al., 2000). 
That animal cells release FAEs in a stimuls-dependent manner suggests that these 
compounds may participate in cell-to-cell communication. Further support for 
this idea came from the discovery that AEA serves as an endogenous ligand for 
cannabinoid receptors. PEA, OEA and SEA cannot be considered endocannabi-
noids, since they have very low affinity for the cannabinoid receptors. Research 
on FAEs mediated signaling has been largely confined to the endocannabinoid 
AEA, however it is now becoming apparent that the cannabinoid receptor-
inactive, saturated and monounsaturated FAEs are of physiological and patho-
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logical interest as well.  
 
HOW IS OEA SYNTHESIZED? 
A model for OEA biosynthesis is illustrated schematically in Figure 2. Its first 
step is the transfer of a fatty acid residue from the sn-1 position of phosphatidyl-
choline to the free amine group of phosphatidylethanolamine. This reaction is 
catalyzed by an N-acyltransferase, which remains to be molecularly identified, 
and yields a heterogeneous family of N-acyl phosphatidylethanolamine (NAPE) 
species. The second step is the cleavage of NAPEs to produce other fatty acid 
ethanolamides (FAEs), including OEA, a step catalyzed by NAPE-specific phos-
pholipaseD (NAPE-PLD) (Okamoto et al., 2004). 
 
HOW IS OEA INACTIVATED? 
Once released, polyunsaturated FAEs are transported back into cells (Beltramo et 
al., 1997; Cravatt et al., 1996; Désarnaud et al., 1995) and eventually broken 
down to fatty acid and ethanolamine by an intracellular fatty acid amide hydro-
lase (FAAH) (Figure 3) and/or N-acylethanolamine-hydrolyzing acid amidase 
(NAAA), a lysosomal cysteine hydrolase (Tsuboi et al., 2005). 
It has been shown that AEA transport meets four key criteria of a carrier-
mediated process: saturability, fast rate, temperature-dependence, and substrate 
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selectivity (Di Marzo et al., 1994 ; Beltramo et al., 1997; Hillard et al., 1997). 
AEA transport differs from that of amine and amino acid transmitters in that it 
does not require cellular energy or external Na+, implying that it may be mediated 
through facilitated diffusion (Beltramo et al., 1997; Hillard et al., 1997; Piomelli 
et al., 1999; Rakhshan et al., 2000). As far as OEA is concerned it is not clear yet 
if a specific transporter is responsible for its uptake into the cells.  
FAAH (previously called ‘anandamide amidohydrolase’ and ‘oleamide hydro-
lase’) is an intracellular membrane-bound protein whose primary structure dis-
plays significant homology with the ‘amidase signature family’ of enzymes (Cra-
vatt et al., 1996; Giang and Cravatt, 1997). It acts as a hydrolytic enzyme for fatty 
acid ethanolamides such as AEA, but also for esters such as 2-AG (Goparaju et 
al., 1998, Lang et al., 1999) and primary amides such as oleamide (Cravatt et al., 
1995). Site-directed mutagenesis experiments indicate that this unusually wide 
substrate preference may be due to a novel catalytic mechanism involving the 
amino acid residue lysine 142. This residue may act as a general acid catalyst, fa-
voring the protonation and consequent detachment of reaction products from the 
enzyme’s active site (Patricelli et al., 1999). Three serine residues that are con-
served in all amidase signature enzymes (S241, S217 and S218 in FAAH) may 
also be essential for enzymatic activity: serine 241 may serve as the enzyme’s 
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catalytic nucleophile, while serine 217 and 218 may modulate catalysis (Patricelli 
et al., 1999). 
 
OEA BIOLOGICAL ROLE 
Although FAEs were first described four decades ago (Colodzin et al., 1963), 
they did not attract much attention until the discovery that AEA is an endogenous 
ligand for cannabinoid receptors, G protein-coupled receptors targeted by the 
marijuana constituent delta-9-tetrahydrocannabinol (THC) (Devane et al., 1992). 
AEA is now established as a brain endocannabinoid messenger (Piomelli, 2003) 
and multiple roles for other FAE have also been proposed (Mazzari et al., 1996; 
Calignano et al., 1998; Rodriguez de Fonseca et al., 2001). One emerging func-
tion of these lipid mediators is the regulation of feeding behavior. AEA causes 
overeating in rats because of its ability to activate cannabinoid receptors (Berry et 
al., 2002). This action is of therapeutic relevance: cannabinoid agonists such as 
THC are currently used to alleviate anorexia and nausea in AIDS patients, 
whereas the CB1 antagonist rimonabant (SR141716A) was recently found to be 
effective in the treatment of obesity (Berry et al., 2002).  
In contrast to AEA, OEA decreases food intake and body weight gain through a 
cannabinoid receptor-independent mechanism (Fu et al., 2003; Guzman et al., 
2004; Lo Verme et al., 2005). Despite its similarities with AEA, OEA does not 
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bind, indeed, to cannabinoid receptors and its functional roles have remained elu-
sive for many years, until it was demonstrated that OEA may serve as physiologi-
cal regulator of satiety and energy balance (Rodriguez de Fonseca et al., 2001; 
Gaetani et al., 2003; Oveisi et al., 2004; Nielsen et al., 2004). In the rat proximal 
small intestine, endogenous OEA levels decrease during fasting and increase 
upon refeeding, likely as a result of local alterations in OEA biosynthesis and/or 
hydrolysis (Rodriguez de Fonseca et al., 2001). Dietary fat intake represents the 
main stimulus for OEA synthesis in enterocytes (Schwartz et al., 2008). These pe-
riprandial fluctuations in OEA mobilization may represent a previously unde-
scribed signal that modulates between-meal satiety. Pharmacological studies have 
shown, indeed, that, when administered as a drug, OEA produces profound 
anorexiant effects in rats and mice (Rodriguez de Fonseca et al., 2001; Nielsen et 
al., 2004; Proulx et al., 2005), which are due to selective prolongation of feeding 
latency and post meal interval (Rodriguez de Fonseca et al., 2001; Oveisi et al., 
2004). The behavioral selectivity of OEA is further underscored by the fact that 
this lipid amide does not induce visceral malaise, anxiety-like behaviors or stress 
hormone release (Rodriguez de Fonseca et al., 2001; Proulx et al., 2005).  
 
OEA PHARMACOLOGICAL TARGET 
The nuclear receptor peroxisome proliferator-activated receptor-(PPAR-alpha) 
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Figure 4 is a key regulator of lipid metabolism and energy balance in mammals 
(Desvergne et al., 1999). Although OEA may bind to multiple receptors (Wang et 
al., 2005; Overton et al., 2006), three distinct lines of evidence indicate that 
PPAR-alpha mediates the satiety-inducing effects of this compound. Firstly, OEA 
binds with high affinity to the purified ligand-binding domain of mouse and hu-
man PPAR-alpha (KD 37 and 40 nM, respectively) and activates with high po-
tency PPAR-alpha-driven transactivation in a heterologous expression system 
EC50 = 120 nM (Fu et al., 2003). Secondly, synthetic PPAR-alpha agonists, such 
as the compounds GW7647 and Wy-14643, exert anorexiant effects that are due 
to a selective increase in feeding latency and, thus, are behaviorally identical to 
those produced by OEA (Fu et al., 2003). Thirdly, mutant mice in which the 
PPAR-alpha gene has been deleted by homologous recombination (PPAR-alpha-/- 
mice) do not respond to OEA or synthetic PPAR-alpha agonists, although they re-
tain normal responses to two mechanistically different anorexiants, CCK-
octapeptide (CCK-8) and fenfluramine (Fu et al., 2003). Together, the findings 
outlined above suggest that endogenous OEA, produced in the proximal small in-
testine during feeding, regulates between-meal satiety by activating PPAR-alpha. 
Although PPAR-alpha receptor are expressed also in the CNS, some evidences 
suggest that the anorexiant effect of OEA is mainly peripheral, rather than attrib-
utable to direct activation of central PPAR-alpha. In fact, OEA does not affect 
 8 
food intake when injected into the brain ventricles, and its anorexic actions are 
prevented when peripheral sensory fibers are removed (Rodriguez de Fonseca et 
al., 2001; Fu et al., 2003). Moreover, both sistemic and oral administration of the 
compound cause a sustained decrease of food intake in free-feeding rats, which is 
accompanied by an increase in OEA levels in the gastrointestinal tract and in 
plasma, but not in the brain (Oveisi et al., 2004).  
Since the anorexiant effect of OEA appears to be selective and, in particular, not 
related to malaise and nausea, the question arises of which, if any, are the central 
nervous system (CNS) structures recruited downstream to OEA peripheral recep-
tor activation and that are responsible for the behavioral effects of this lipid on 
feeding. 
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CHAPTER II 
 
STANDARDIZED ANALYSIS OF c-fos mRNA EXPRESSION 
PATTERN IN RAT BRAIN AUTORADIOGRAPHY USING 
FREEWARE IMAGING SOFTWARE: 
 
INTRODUCTION: 
The immediate early gene c-fos is one of the most studied genes in the CNS as a 
marker for neuronal activation (Edwards et al., 1999; Abraham and Kovacs, 
2000; Konkle and Bielajew, 2004). The c-fos belongs to the family of immediate-
early transcription factor genes that are believed to function in coupling short-
term signals to long-term changes in cellular phenotype by orchestrating changes 
in target gene expression (Curran and Morgan, 1995). 
The expression of c-fos, which is normally low, can be increased by a number of 
pharmacological, physiological, and behavioral manipulations (Morgan and Cur-
ran, 1989; Herrera and Robertson, 1996). Therefore, the measurement of c-Fos 
protein levels, the product of c-fos gene, has been used as a marker for activated 
neurons (Hoffman et al., 1993; Edwards et al., 1999; Abraham and Kovacs, 
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2000). In recent years, c-Fos protein and c-fos mRNA have been widely used as 
markers for the impact of drug treatments (Young et al., 1991; Kreuter et al., 
2004), experimental procedures (Worley et al., 1993; Del Bel et al., 1998), and 
environmental changes such as light (Rusak et al., 1992), temperature (Bratincsak 
and Palkovits, 2004), and novelty/stress (Emmert and Herman, 1999; Amico et 
al., 2004). 
It is clear that c-fos gene expression is one of the most important CNS parameters 
in the field of neuroscience research. However, the traditional method of studying 
c-fos gene expression by examining c-Fos-positive neurons is a labor intensive 
task (Snowball et al., 2000; Nakagawa et al., 2003; Sinniger et al., 2004). A more 
rapid way to analyze activated brain areas is to investigate the expression of c-fos 
mRNA by in situ hybridization with a radiolabeled probe that allows the detection 
of hybridized areas by autoradiography. However, c-fos mRNA expression is 
relatively low in basal conditions, therefore autoradiography of c-fos hybridized 
brain does not show a strong signal. As a consequence, the identification of brain 
areas activated after an experimental treatment can often be very difficult and 
usually relies upon the anatomical skills of the experimenter. The identification 
step is usually followed by the quantification procedure consisting of measuring 
the optical density of a sampling area of standard size for each hybridized brain 
region. 
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The aim of the study was to develop and validate a novel method for fast quanti-
tative analysis of the optical density in the autoradiographic signal of hybridized 
slides. 
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METHODS 
Animals and Experimental Conditions 
Adult male Wistar rats were housed in groups of 6 rats per cage and kept at con-
stant ambient temperature and humidity under a steady light/dark cycle with free 
access to food and water. 
The day of the experiment the rats were divided in two experimental groups. In 
the first group, each rat was left undisturbed in its own cage and represented our 
control group; in the second group, each rat was individually transferred to an 
empty cage containing fresh sawdast, where it was kept for one hour, before be-
ing sacrificed and represented our treated group (called manipulated group). Rats 
were sacrificed with CO2 and decapitated. Their brains were rapidly excised, 
snap frozen in 2-methylbutane (-50°C) and stored at -80°C. Even though it takes 
several seconds for the animal to succumb after CO2 inhalation, this method of 
sacrifice does not influence the level of expression of our gene of interest (Miller, 
1991). 
Tissue preparation  
Brains were cut on a cryostat set at -20°C into four series of serial coronal sec-
tions at 20 µm thickness. Sections were thaw-mounted on Superfrost plus slides 
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(Menzel Glaser, Germany), three sections per slides, and immediately fixed in 
phosphate-buffered 4% paraformaldehyde for 1 hour. Sections were washed three 
times in 50 mM PBS, pH 7.4, for 10 min each before the slides were transferred 
for 10 min to 0.4% Triton X-100. The slides were rinsed in double distilled water 
(ddH2O) and transferred to 0.1 M triethanolamine, pH 8.0. Acetic anhydride was 
added under stirring to a final concentration of 0.25% (v/v), and sections were 
further incubated for 10 min. The slides were rinsed twice in 50mM PBS, pH 7.4, 
for 10 min each before dehydration in 50 and 70% 2-propanol. The air-dried sec-
tions were stored at -20°C until the hybridization. Slides can be stored this way 
for several months with no apparent reduction in hybridization signal intensity. 
In all these pre-hybridization steps common RNAse-free procedures were adopted 
to minimize degradation of mRNAs within the tissue sample and to ensure a 
strong hybridization signal. 
Radiolabeled cRNA probe 
Antisense c-fos riboprobe was transcribed from 1 µg Pst I-linearized recombinant 
clone pBS/rfos with T7 RNA polymerase in the presence of both uridine-5'-[!-
35S]thio]triphosphate and cytidine-5'-[!-35S]thio]triphosphate. The resulting 
cRNA was complementary to positions 583-1250 of clone pc-fos(rat)-1 (Curran 
et al., 1987). The sense RNA sequence was generated from the same template us-
ing T3 RNA polymerase after linearization with Pvu II.  
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After transcription, the probes were subjected to mild alkaline hydrolysis as de-
scribed previously (Angerer et al., 1987) and purified on G-50 column (Bio-rad), 
according to the manufacturer’s instructions. 
Hybridization with radioprobes  
The radioprobes were diluted in hybridization buffer (3X SSC, 50 mM NaPO4, 
10 mM DTT, 1X Denhardt’s solution, 20 mg/ml yeast tRNA, 10% dextran sul-
fate, and 50% formamide) to yield concentrations of 75,000 dpm/µl. Brain sec-
tions were coated with 55 µl of hybridization solution, slides were coverslipped 
and incubated for 16 h at 60°C in a humid chamber. Coverslips were removed, 
and slides were washed in 2X SSC and 1X SSC (20 min each), followed by incu-
bation for 30 min at 37°C in RNase buffer (10 mM Tris, pH 8.0, 0.5 M NaCl, and 
1 mM EDTA) containing 1 U/ml RNase T1 and 20 µg/ml RNase A, to reduce 
background. The slides were washed at room temperature in 1X and 0.2X SSC 
(20 min each), then under high stringency conditions at 60°C in 0.2X SSC (60 
min), and at room temperature in 0.2X SSC (10 min). Finally, they were dehy-
drated in ascending alcohols series and air dried for about 2 hours. 
Slides were exposed to Kodak Biomax film (Sigma Aldrich) for 3 days. The films 
were developed according to the manifacturer’s protocol. Coexposure with two 
calibrated microscales (0.13-35.0 µCi/g and 4.47-400 µCi/g, respectively) of 14C-
labeled plastic standards (American Radiolabeled Chemicals Inc.) permitted 
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quantification of the 35S radioisotope (Miller, 1991). The specificity of the hy-
bridization signal was ascertained by hybridization of adjacent sections labeled 
with the corrensponding sense probe. 
For emulsion autoradiography, selected sets of slides were dipped into NTB Ko-
dak autoradiography emulsion (Integra Biosciences, Fernwald, Germany) and ex-
posed for 18 days (c-fos hybridization) at 4°C. Autoradiograms were developed 
according to manifacturer’s instructions. Finally slides were stained with cresyl 
violet staining. In particular, sections were incubated with warm 1% cresyl violet 
acetate (Sigma Aldrich) for 10 min. Stained slides were rinsed in ethanol, cleared 
in xylene, and coverslipped. Slices were examined in bright-field under a NIKON 
80i ECLIPSE microscope. 
Autoradigraphic quantitative analysis 
Three different procedures were followed, being the first one our new procedure 
and the other two classic procedures that we used to validate the new protocol: 1) 
Whole area procedure; 2) Sampling area procedure; 3) Grain counting procedure. 
Quantitative analysis of the autoradiographic film was performed using the 
freeware software from the National Institutes of Health (Scion Image software). 
Autoradiography films were first scanned (Epson perfection 3200 PHOTO) at 
high resolution (900 dpi). Resulting images were divided into single slice crops 
for quantification. Optical densities were converted into radioactivity concentra-
 28 
tions by densitometric analysis of 14C-miscoscale standards that were used to cre-
ate a calibration curve.  
Whole area procedure 
To analyze the optical density of the regions of interest (ROI) from each slice in-
cubated with the antisense probe, a crop template was created from the brain ta-
bles illustrated on the “The Rat Brain Atlas” by Paxinos & Watson (1998). In par-
ticular, a proper plate was chosen that could correspond to the brain slice to ana-
lyze. Then, the pdf file from the atlas CD-ROM was transformed into a tiff file, 
calculating the proper pixel to mm ratio that reproduced the same resolution and 
the same size of the brain crop to analyze (Figure 1). 
The tiff file containing the drawing from the atlas was opened with the IMAGE J 
software. The wand tool was used to create the selection of each ROI from the at-
las template by simply clicking inside near the right edge, or outside to the left of 
the ROI on the template (Figure 2).  The drawing of the atlas was then superim-
posed on the slice crop. All the ROIs created from the template were then applied 
to the new image containing the brain crop and the atlas drawing, and the optical 
density of each ROI was measured in one click (Figure 2). The template obtained 
from the atlas was also superimposed to the image of the Nissl stained slices 
taken with microscope. 
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Sampling area procedure 
Initial quantification of c-fos mRNA hybridization signal was conducted on 
autoradiographs in sampled regions of the secondary motor cortex (M2) (Figure 
3). This method was performed by arbitrarily circling an area on the region of 
interest and measuring its optical density with the calibration curve created with 
14C-miscoscale standards (Ferguson et al., 2004). 
Grain counting procedure 
Assessment of grain density over neurons of secondary motor cortex was per-
formed by a semiautomated computerized grain-counting protocol. Images of 
lightly counterstained neurons of secondary motor cortex (M2) were captured at 
2X in bright-field under a NIKON 80i ECLIPSE microscope (Figure 4). Square 
areas were manually sampled, and area determinations were made within Image 
Software. Images were then thresholde to visualize grains only, and area determi-
nations were repeated. The sampling template was then moved to an unhybridized 
region of tissue to establish background grain area. Results were expressed as the 
percent of area occupied by grains (Bowers et al., 1998), calculated as: 
                           (sampled area occupied by grains) 
% area  =       – (background area occupied by grains)          X 100      
                            Total area of sampling template  
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RESULTS AND DISCUSSION  
Analysis of c-fos hybridizated slices showed that the manipulation treatment 
evokes a significant increase in c-fos mRNA level in secondary motor cortex 
(M2). Here, we compared the induction of c-fos mRNA in brain of rats exposed 
to manipulation with three different method of quantification: whole area, sam-
pling area, and grain counting procedure. The purpose of this experiment was to 
develop and validate a rapid way for quantification of the optical density of hy-
bridized areas that does not involve either sampling or manually encircling the 
entire region of interest.  
Results obtained from the analysis of optical density and of grain counting are re-
ported in Figure 5. For each set of data we used a two-tailed t-test to compare data 
obtained from manipulated rats to data obtained from control rats.  
The results shown in Figure 5 revealed that the accurancy of the anatomical refer-
ence from the atlas that was the basis of the whole area procedure improved the 
results of the statistical analysis with respect to both the sampling area method 
and the grain counting method. 
The statistical analysis of the optical density measured with the sampling area 
procedure (Figure 5, panel B) gave the following results: t= 30; df = 2, p <0.01  
  
31 
The t-test of the integrated optical density obtained with the whole area procedure 
gave the following results t = 86,65; df = 2, p <0.0001  
Finally, the statistical analysis of the percentage area of c-fos+ cells in the motor 
secondary gave the following results t-test: t =4.943; df =2 p < 0.05 
This study illustrates a novel method to identify the brain areas hybridized with c-
fos mRNA probe by using an unbiased template from “The Rat Brain Atlas” by 
Paxinos and Watson (1998). It describes a rapid way for quantification of the op-
tical density of hybridized areas that does not involve either sampling or manually 
encircling the entire region of interest. 
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CHAPTER III 
 
INVOLVEMENT OF CENTRAL NEUROPEPTIDERGIC 
PATHWAYS IN THE ANOREXIC EFFECT OF 
OLEOYLETHANOLAMIDE 
 
INTRODUCTION: 
Initial data obtained mapping mRNA levels for the activity regulated gene c-fos 
by in situ hybridization showed that, after systemic administration, OEA evokes a 
highly localized increase in c-fos mRNA levels in the nucleus of the solitary tract 
(NTS), the paraventricular nucleus (PVN) and the sopraoptic nucleus (SO) (Rod-
riguez de Fonseca et al., 2001).  
These areas are crucially involved in the regulation of feeding behavior and en-
ergy balance and the stimulation of c-fos expression at these levels after intraperi-
toneal injection of OEA is consistent with the role of this compound as a periph-
eral regulator of satiety.  
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The NTS is the site where vagal afferents from the gastrointestinal tract predomi-
nantly terminate, together with sensory fibres from gustatory receptors and vis-
ceral fibres from the cardiovascular and respiratory systems. NTS neurons are ac-
tivated after feeding, gut distension, intragastric infusion of nutrients or peripheral 
CCK administration.  
Most of the NTS neurons that are activated by CCK or feeding project to the hy-
pothalamus, including PVN and SO (Hillebrand et al., 2002; Moore and Black 
1991). 
The PV and the SO nuclei are both part of the supraoptic region of the hypo-
thalamus. The PVN consists of several distinct cell groups that define the dorsal, 
the ventral and the medial parvocellular sub-nuclei, and the lateral magnocellular 
subnucleus. The SO nucleus consists mainly of large neurons. The magnocellular 
components of both nuclei release two hormones, namely oxytocin (oxy) and 
vasopressin (avp). Increasing evidence suggests that the involvement of oxy and 
avp in a number of homeostatic systems may include appetite control (Hillebrand 
et al., 2002). 
The magnocellular oxy neurons of the SON and PVN project their axons to the 
posterior pituitary where they secrete oxy into the periphery. These neurons also 
release very large amounts of oxy from their dendrites and cell bodies within the 
SON and PVN. Dendritic oxy acts locally to facilitate neuron activity, but is also 
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thought to diffuse to distant sites within the brain; for example, the amygdale 
(Ludwig and Leng, 2006). Parvocellular oxy neurons of the PVN project centrally 
to various hypothalamic, limbic and brainstem regions. In particular, it has been 
reported that these neurons project to the NTS and that this neuronal pathway is 
related to inhibition of food intake (Blevins et al., 2004; Sabatier et al., 2006). 
So central oxytocin systems can provide a multi-level controlling influence on 
other brain regions and, there is growing appreciation that oxy has an important 
role in the regulatory neuronal network mediating satiety (Amico et al., 2005; Ri-
naman et al., 2005; Mantella et al., 2004).Based on these evidence, we hypothe-
sized that oxy neurons, might play a key role in regulating food intake after OEA 
administration. 
We explored such hypothesis by using two complementary approaches: anatomi-
cal/functional and pharmacological/behavioral. First we determined the effects of 
OEA (10 mg kg-1 i.p.) administration on the expression of oxy and avp mRNA in 
both PVN and SON by using in situ hybridization histochemistry. In particular, 
we performed a time-course study, to assess the time-dependent effects of OEA 
and its possible specificity toward one of the two neuropeptides. Second, we ad-
ministered OEA at different doses (5, 10 and 20 mg kg-1, i.p.), and sacrificed rats 
at the time that corresponded to the strongest effect, in order to determine the 
dose-dependent effects of OEA. Third, we determined if OEA causes any altera-
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tion on oxy mRNA expression in the same neurons expressing c-fos. In this case 
we performed a dual in situ hybridization in brain slices obtained from rats treated 
with OEA at the most effective dose and time. Finally, we investigated whether 
the effects observed after OEA administration can be still detected in mice lack-
ing the molecular target of the compound, namely the PPAR-alpha receptors. 
The role of oxy in mediating OEA effects was further investigated by pharmacol-
ogical/behavioral experiments, in which the systemically effective oxy antagonist, 
Atosiban (ATO, 1 mg kg-1 i.p.), was administered prior to OEA treatment, to 
evaluate its effects on preventing OEA-induced anorexia.  
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METHODS 
Animals and experimental conditions 
Adult male Wistar rats (Harlan, Italy) 250-300 g male PPAR-!-/- mice (B6.129S4-
PparatmtGonzN12), and wild-type controls (C57/Bl6) (Germantown, NY) were 
housed in groups of three-four in standard plexiglas cages at a room temperature 
of 22°C. A 12 h light/dark cycle was set with the light on at 6:30 pm. Water and 
standard chow pellets were available ad libitum.  
For in situ hybridization experiments, we accustomed rats to handling and injec-
tion procedures for 7 days. On day 8, we administered vehicle or OEA about 10 
minutes before the dark phase of the light cycle and killed rats with CO2 and de-
capitation 30 min, 1, 2 and 4 hours after treatment. Both a dose-response experi-
ments and a time-course experiment were performed. Mice were treated at the 
same time of the light/dark cycle and were sacrificed 1 hour after treatment. The 
brains were rapidly excised, snap frozen in 2-methylbutane (-50°C) and stored at 
-80°C.  
For behavioral experiments rats were moved to individual cages two days prior to 
test with food pellets and water available ad libitum. On test day they were treated 
before dark onset and left undisturbed for 18 hours.  
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All procedures met the guidelines from the Italian Ministry of Health as well as 
from the US National Institutes of Health for the care and use of laboratory ani-
mals. 
Treatments 
OEA was synthesized in the laboratory (Giuffrida et al., 2000), dissolved in sa-
line/polyethylene glycol/Tween 80 (90/5/5, v/v/v; 2 ml Kg-1) and administered, 10 
min before dark onset, by intraperitoneal (i.p.) injection at dose of 5, 10 or 20 mg 
Kg-1  to free-feeding rats (FFO). Control animals (FFV) received an i.p. injection 
of vehicle. OEA was administered also to free-feeding wild type and PPAR-!-/-  
mice (W-type O and K-out O, respectively) at the dose of 10 mg Kg-1. Control 
mice (W-type V and K-out V, respectively) received injection of vehicle. 
The oxy receptor antagonist atosiban (ATO) 1mg kg-1 was dissolved in saline and 
administered to rats 30 min before OEA or vehicle administration. Control ani-
mals received a saline injection instead of ATO 
Tissue preparation  
Brains were cut on a cryostat set at -20°C into four series of serial coronal sec-
tions at 20 µm thickness. Sections were thaw-mounted on Superfrost plus slides 
(Menzel Glaser, Germany), three sections per slides in the case of rat sections or 
four sections per slides in the case of mouse sections, and immediately fixed in 
phosphate-buffered 4% paraformaldehyde for 1 hour. Sections were washed three 
  
47 
times in 50 mM PBS, pH 7.4, for 10 min each before the slides were transferred 
for 10 min to 0.4% Triton X-100. The slides were rinsed in double distilled water 
(ddH2O) and transferred to 0.1 M triethanolamine, pH 8.0. Acetic anhydride was 
added under stirring to a final concentration of 0.25% (v/v), and sections were 
further incubated for 10 min. The slides were rinsed twice in 50mM PBS, pH 7.4, 
for 10 min each before dehydration in 50 and 70% 2-propanol. The air-dried sec-
tions were stored at -20°C until the hybridization. In all these pre-hybridization 
steps common RNAse-free procedures were adopted to minimize degradation of 
mRNAs within the tissue sample and to ensure a strong hybridization signal. 
Radiolabeled cRNA probes 
Levels of c-fos mRNA, oxy mRNA and avp mRNA were examined in the brain 
sections using in situ hybridization of 35S-labeled RNA probes. 
Antisense c-fos riboprobe was transcribed from 1 µg Pst I-linearized recombinant 
clone pBS/rfos with T7 RNA polymerase in the presence of both uridine-5'-[!-
35S]thio]triphosphate and cytidine-5'-[!-35S]thio]triphosphate. The resulting 
cRNA was complementary to positions 583-1250 of clone pc-fos(rat)-1 (Curran 
et al., 1987). The sense RNA sequence was generated from the same template us-
ing T3 RNA polymerase after linearization with Pvu II.   
Both antisense oxy-riboprobe and antisense avp-riboprobe were generated from 
Xho I-linearized recombinant clone pCRII/OX and pCRII/AVP, respectively, us-
 48 
ing Sp6 RNA polymerase. Both sense riboprobes were transcribed from BamH I-
linearized templates with T7 RNA polymerase. 
After transcription, the probes were subjected to mild alkaline hydrolysis as de-
scribed previously (Angerer et al., 1987) and purified on G-50 column (Bio-rad), 
according to the manufacturer’s instructions. 
Digoxigenin-labeled cRNA probes 
Digoxigenin-labeled probes were synthesized in an in vitro transcription reaction 
(20 µl) containing 1 µg linearized DNA, 0.1 mM digoxigenin-labeled rUTP 
(Roche Diagnostic Lab), 10 mM unlabeled rGTP, rATP and rCTP, 20 U RNAse 
inhibitor  and 20 U appropriate RNA polymerase (the same used for radioprobe 
synthesis). The transcription reaction was run at 37 °C for 3 hours , and DNAse I 
was added and incubated at 37 °C for an additional 15 min. The DNAse reaction 
was terminated by adding 2 µl of 0.2 M EDTA and the digoxigenin-labeled 
probes were then purified on a G-50 column (Bio-rad). After purification, the op-
tical density of the stock labeled probe was determined with spectrophotometer, 
considering that a reading of 1 at 260 nm wavelength corresponds to approxi-
mately 40 µg/ml for single-stranded RNA (Miller et al., 1993). Probe was diluted 
in RNAse-free distilled water to a final concentration of 200 ng/ml in the hybridi-
zation cocktail.  
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Hybridization with radioprobes and autoradiography 
The radioprobes were diluted in hybridization buffer (50% deionized formamide, 
10% dextran sulfate, 600 mM sodium chloride, 10 mM Tris, pH 7.5, 1 mM Na+-
EDTA, 1X Denhardt’s solution, 20 mg/ml yeast tRNA, 10% dextran sulfate, and 
50% formamide, 100 µg/ml sonicated selmone sperm) to yield concentrations of 
75,000 dpm/µl. Brain sections were coated with 55 µl of hybridization solution, 
slides were coverslipped and incubated for 16 h at 60°C in a humid chamber. 
Coverslips were removed, and slides were washed in 2X SSC and 1X SSC (20 
min each), followed by incubation for 30 min at 37°C in RNase buffer (10 mM 
Tris, pH 8.0, 0.5 M NaCl, and 1 mM EDTA) containing 1 U/ml RNase T1 and 20 
µg/ml RNase A, to reduce background. The slides were washed at room tempera-
ture for 5 min in 1X SSC  and for 30 min 0.2X SSC , then under high stringency 
conditions at 60°C in 0.2X SSC (60 min), and at room temperature in 0.2X SSC 
(30 min). Finally, they were dehydrated in ascending alcohols series and air dried 
for about 30 min. 
Slides were exposed to Kodak Biomax film (Sigma Aldrich) either for 8 hours (in 
the case of oxy or avp hybridization) or for 3 days (in the case of c-fos hybridiza-
tion). The films were developed according to the manifacturer’s protocol. Coex-
posure with two calibrated microscales (0.13-35.0 µCi/g and 4.47-400 µCi/g, re-
spectively) of 14C-labeled plastic standards (American Radiolabeled Chemicals 
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Inc.) permitted quantification of the  autoradiographic signal of hybridized brain 
regions (Miller, 1991). The specificity of the hybridization signal was ascertained 
by hybridization of adjacent sections labeled with the corrensponding sense 
probe. 
For emulsion autoradiography, selected sets of slides hybridized with c-fos ribo-
probe were dipped into NTB Kodak autoradiography emulsion (Integra Bio-
sciences, Fernwald, Germany) and exposed for 18 days at 4°C. Autoradiograms 
were developed according to manifacturer’s instructions. 
Data analysis 
Autoradiography films were scanned (Epson perfection 3200 PHOTO) at high 
resolution (900 dpi). The Atlas of Paxinos and Watson (1998) was used to define 
the locations and boundaries of the brain structures of interest (PVN and SON). 
Quantitative analysis of hybridized signals on the autoradiographic film was per-
formed using Scion Image software (NIH, USA). Optical densities were con-
verted into radioactivity concentrations by densitometric analysis of 14C-
miscoscale standards, so as to create a calibration curve. The film exposure times 
(i.e. 8 hours or 3 days) were optimized to obtain linear calibration curves with 
ranges of optical densities that included the optical densities of hybridization sig-
nals for each brain area of interest. For each calibration curve we tested the linear-
ity by linear regression and statistical analysis and in all cases we obtained a lin-
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ear coefficient r2>0.9 and a non significant (p>0.05) departure from linearity. In 
every brain section, background levels of hybridization were obtained from read-
ings in white matter structures such as the corpus callosum, where minimal bind-
ing would be expected to occur and subtracted from the mean reading of the area 
of interest. Integrated optical density (O.D.) values (radioactivity x area) of hy-
bridized area were measured considering the right and left areas of interest to-
gether. Measurements were obtained in at least four consecutive tissue sections 
containing the desired structure (Lee et al., 2005). Tissue sections were chosen, 
among those hybridized, to be similar in each experimental group. To chose the 
proper sections each slide used for the in situ hybridization was examined in 
phase contrast under a NIKON 80i ECLIPSE microscope equipped with a DS-U1 
digital camera. Only those brain slices corresponding to the selected set of sec-
tions were considered for the quantitative analysis and were selected for emulsion 
autoradiography. The same microscope was used to visualize autoradiograms un-
der dark-field illumination. For each slice a large image was obtained by stitching 
separately captured images from the same brain slice acquired at 10X magnifica-
tion (0.25mm/px at 2560x1920 format quality), by using NIS-elements BR soft-
ware (NIKON).  
Data from quantitative analysis of autoradiography films are reported as the mean 
percent of the appropriate control subjects’ relative integrated density readings ± 
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SEM. In particular, for purposes of relative comparisons, we established as 100% 
the average reading from subjects of the FFV-60 min in the time-course experi-
ments, the average reading from subjects of the FFV in the dose-response ex-
periment and average reading obtained from the W-Type V subjects in the ex-
periments on mice. Statistical significance for mRNA expression was determined 
by two-way or one-way ANOVA, depending from the experimental setting, and 
multiple comparisons were performed by Tukey’s post hoc test. In all instances, 
statistical significance threshold was set at p<0.05. 
Hybridization with digoxigenin probes and staining 
Hybridization with digoxigenin probes was based on a protocol slightly modified 
from that described by Miller and colleagues in 1993 (Miller et al., 1993). Di-
goxigenin probes were diluted in hybridization buffer (50% deionized formamide, 
10% dextran sulfate, 600 mM sodium chloride, 10 mM Tris, pH 7.5, 1 mM Na+-
EDTA, 1X Denhardt’s solution, 20 mg/ml yeast tRNA, 10% dextran sulfate, and 
50% formamide, 100 µg/ml sonicated selmone sperm) using 200 ng/ml and fur-
ther steps were similar to does followed in the radioactive hybridization. For 
blocking step, the slides were treated with 2% normal goat serium (NGS) and 
0,05 % Triton X-100 in 2X SSC 4°C overnight. After the blocking step, slides 
were washed twice (10 min) in Buffer 1 (0.1 M Tris-HCl, 0.15 M NaCl, pH 7.5) 
and then incubated for 3 hr at 30°C with the antidigoxigenin antibody, conjugated 
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to alkaline phosphatase (Roche Diagnostic Lab.), which was diluited (1:500) in 
buffer 1 containing 1% NGS and 0,3% Triton X-100. Slides were, then, washed 
in Buffer 1 (10 min), and then washed in Buffer 2 (100 mM Tris-HCl, 100 mM 
NaCl, 50 mM MgCl2, pH 9.2, 10 min). Digoxigenin-labeled probes were visual-
ized by incubating the slides in a chromogen solution with 340 µg/ml nitroblue 
tetrazolium chloride, and 175 µg/ml 5-bromo-4-chloro-3-indolyl-phoshate in 
Buffer 2 overnight at 4 °C. The reaction was blocked by incubating the slides in 
10 mM tris-HCl (pH 8) and 1mM EDTA (Buffer 3) at room temperature for at 
least 2 hours. The slides were dehydrated in ascending alcohols series and air 
dried for about 30 min. Finally slides were stained with Nissl staining. In particu-
lar, sections were incubated with warm 1% cresyl violet acetate (Sigma Aldrich) 
for 10 min. Stained slides were rinsed in ethanol, cleared in xylene, and cover-
slipped. Slices were examined in bright-field under a NIKON 80i ECLIPSE mi-
croscope. 
Dual in situ hybridization 
Slides were hybridized with a mixture of digoxigenin-oxy-riboprobe and radiola-
beled c-fos riboprobe both diluted in the same hybridization buffer (50% deion-
ized formamide, 10% dextran sulfate, 600 mM sodium chloride, 10 mM Tris, pH 
7.5, 1 mM Na+-EDTA, 1X Denhardt’s solution, 20 mg/ml yeast tRNA, 10% dex-
tran sulfate, and 50% formamide, 100 µg/ml sonicated selmone sperm) at the 
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same final concentration used in the single hybridization. This probe cocktail was 
applied to the tissue (60 µl) and sections were coverslipped. Slides were placed in 
a moist chamber and incubated overnight at 60 °C. After incubation the colocali-
zation of signals were reveled with immunocytochemical detection of digoxigenin 
–labeled probe as described above and with autoradiographic emulsion for radio-
labeled probe into the same slides. Each slide used for the dual in situ hybridiza-
tion was stained with Nissl staining. For detection of radiolabeled probes with 
autoradiographic emulsion we capturred an image of each section in dark field 
while digoxigenin probes were visualized in brightfield microscopy. A merge of 
the two images of the same section was obtained to evaluate co-localization of the 
two hybridized probes.  
Analysis of feeding behavior  
Food intake was recorded with an automated system (PRS Italia), consisting of 6 
cages equipped with food trays connected to weight sensors, with lickometers and 
with sensors for food access. The food trays contained standard chow pellets and 
were accessible to the rats through a square window in the wall of the cage 
crossed by an infrared beam (sensor for food access). Each time food was re-
moved from the tray, the computer recorded the episode, as an event of food ac-
cess and the amount of food retrieved, corrected from the food spillage left in the 
tray. Food access was detected each time the head of the animal interrupted the 
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infrared beam of the window, also when no food was taken from the tray. The 
lickometer counted the licks each time the animal consumed water.  
Rats were habituated to the test cages for 2 days prior to trials and had free access 
to food and water. Experiments with free-feeding rats began at onset of the  
dark phase and lasted 18 hours. Total food intake was measured and expressed as 
g Kg-1. Total number of food acces and total number of licks were also measured. 
Data were analyzed by one way ANOVA and by Tuckey’s post hoc test for mul-
tiple comparisons. 
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RESULTS 
 
C-fos hybridization 
Representative c-fos mRNA-autoradiography of brain sections obtained from a 
rat treated with vehicle (panel A) and a rat treated with OEA (10 mg kg-1) (panel 
B), 60 min before being killed is showed in Figure1. The lack of autoradiographic 
signal in sections hybridized with c-fos sense probe (representative section in 
panel C) demonstrates the good quality of c-fos riboprobe.  
Analysis of c-fos hybridizated slices showed that the systemic administration of 
OEA evokes an increase of c-fos mRNA levels in two hypothalamic nuclei: the 
Paraventricular nucleus (PVN) and the Supraoptic nucleus(SO). For each nucleus 
the results from densitometric analysis of autoradiography signal were expressed 
as percentage integrated optical density and analyzed by two-way ANOVA, con-
sidering the following factors: treatment and time.  
 
C-fos hybridization in PVN: time course experiment  
The results are shown in Figure 1, (panel D). The two-way ANOVA of integrated 
optical density in the PVN revealed the following results:  
F (treatment) = 82,965; df = 1 / 91, p <0.001  
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F (time) = 10,028; df = 1 / 91, p <0.01  
F (treatment x time) = 9,120 df = 1 / 91, p <0.01  
The multiple comparisons performed by  Tukey’s post hoc test showed that the 
treatment with OEA produces a statistically significant increase in c-fos inte-
grated optical density, 30 minutes (p <0.001) and 1 hour after OEA administra-
tion (p <0.001). 
 
C-fos hybridization in SO: time course experiment 
The results are shown in Figure 1, (panel E). The two-way ANOVA of integrated 
optical density in SO provided the following results:  
F (treatment) = 14,382; df = 1 / 47, p <0.001  
F (time) = 1,195, df = 1 / 47; n.s.  
F (treatment x time) = 4,838 df = 1 / 47, p <0.05 
The multiple comparisons performed by the Tukey’s test showed that the OEA 
treatment produces a statistically significant increase in c-fos integrated optical 
density 1h (but not 30 minutes) after the administration (p <0.001). 
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Oxytocin hybridization 
Representative oxy mRNA-autoradiography of brain sections obtained from a rat 
treated with vehicle (panel A) and a rat treated with OEA (10 mg kg-1) (panel B), 
60 min before being killed is showed in Figure 2. The hybridization with the an-
tisense oxy mRNA probe has shown a highly specific strong hybridization in the 
PVN and SO nuclei. The lack of autoradiographic signal in sections hybridized 
with oxy sense probe (representative section in panel C) demonstrates the good 
quality of oxy riboprobe.  
For each nucleus the results from densitometric analysis of autoradiography sig-
nal were expressed as percentage integrated optical density and analyzed by two-
way ANOVA, considering the following factors: treatment and time.  
 
OXY Hybridization in the PVN: time course experiment 
The results are shown in Figure 2, (panel D). The two-way ANOVA of integrated 
optical density in the PVN provided the following results:  
F (treatment) = 4,650, df = 1 / 230, p <0.05  
F (time) = 4,289, df = 2 / 230, p <0.05.  
F (treatment x time) = 2,353 df = 2 / 230; n.s.  
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The multiple comparisons performed by the Tukey’s test showed that OEA treat-
ment produces a statistically significant increase of integrated optical density (p 
<0.05) 1h after OEA administration.  No alteration has been observed 2 hours and 
4 hours after OEA administration. 
 
OXY Hybridization in the  SO: time course experiment 
The results are shown in Figure 2, (panel E). The two-way ANOVA of integrated 
optical density in the SO revealed the following results:  
F (treatment) = 14,505; df = 1 / 198, p <0.001  
F (time) = 0,094, df = 2 / 198; n.s.  
F (treatment x time) = 1,098 df = 2 / 198; n.s.  
The multiple comparisons performed by Tukey’s test showed that OEA admini-
stration produces a statistically significant increase of integrated optical density  1 
hour (p <0.05) and 2 hours (p <0.05) after  treatment, while no alteration has been 
observed after 4 hours. 
 
AVP hybridization 
Representative avp mRNA-autoradiography of brain sections obtained from a rat 
treated with vehicle (panel A) and a rat treated with OEA (10 mg kg-1) (panel B), 
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60 min before being killed is showed in Figure 3. The hybridization with the an-
tisense avp mRNA probe has shown a highly specific strong hybridization in the 
PVN and SO nuclei. The lack of autoradiographic signal in sections hybridized 
with avp sense probe (representative section in panel C) demonstrates the good 
quality of avp riboprobe.  
For each nucleus the results from densitometric analysis of autoradiography sig-
nal were expressed as percentage integrated optical density and analyzed by two-
way ANOVA, considering the following factors: treatment and time.  
 
AVP hybridization in the PVN: time course experiment 
The results are shown in Figure 3, (panel D). The two-way ANOVA of integrated 
optical density in the PVN revealed the following results:  
F (treatment) = 0,004, df = 1 / 148; n.s.  
F (time) = 5,563, df = 2 / 148, p <0.01  
F (treatment x time) = 1,349 df = 2 / 148; n.s. 
These results indicate that OEA treatment does not affect the avp mRNA expres-
sion in the PVN nucleus. 
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AVP hybridization in the SO: time course experiment 
The results are shown in Figure 3, (panel E). The two-way ANOVA of integrated 
optical density in the SO provided the following results:  
F (treatment) = 0,821, df = 1 / 184; n.s.  
F (time) = 5,968, df = 2 / 184, p <0.01  
F (treatment x time) = 0,208 df = 2 / 184; n.s.  
These results indicate that OEA treatment does not affect the mRNA expression 
of avp in the SO nucleus. 
 
OXY Hybridization in the PVN: dose-response experiment  
The results are shown in Figure 4, (panel A). The one-way ANOVA of integrated 
optical density in the PVN revealed the following results: F = 11,83, df = 3 / 127, 
p <0.01.  
The multiple comparisons performed by Tukey’s test showed that the treatment 
with OEA 10 mg/kg, produces a statistically significant increase of integrated op-
tical density (p <0.01). No significant increase of the integrated optical density 
was found following the administration of OEA at either 5 mg/kg or 20 mg/kg . 
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OXY Hybridization in the SO: dose-response experiment 
The results are shown Figure 4, (panel B). The one-way ANOVA of integrated 
optical density in SO revealed the following results: F = 6,417, df = 3 / 153, p 
<0.001 The multiple comparisons performed by the Tukey’s test showed that 
OEA treatment produces a statistically significant increase of integrated optical 
density when administered at the dose of 10 mg/kg (p<0.01). No significant in-
crease of the integrated optical density was found after 5 mg/kg and 20 mg/kg 
OEA injection. 
 
Dual in situ hybridization 
The analysis of brain slices hybridized with both c-fos and oxy probes has shown 
that >90% of c-fos hybridization coincides with the oxy hybridization in animals 
treated with OEA (10 mg kg-1), 60 min before being killed (Figure 5).  
 
Oxytocin hybridization in PPAR-! -/-  and wild type mice  
Representative oxy mRNA-autoradiography of brain sections obtained from: free-
feeding wild type mice treated either with vehicle (panel A) or OEA (10 mg kg-1) 
(panel B) and free-feeding PPAR-alpha -/- mice treated either with vehicle (panel 
E) or OEA (10 mg kg-1) (panel F), 60 min before being killed is showed in Fig-
  
63 
ure 6. The hybridization with the antisense oxy mRNA probe has shown a highly 
specific strong hybridization in the PV and SO nuclei.  
For each nucleus the results from densitometric analysis of autoradiography sig-
nal were expressed as percentage integrated optical density and analyzed by two-
way ANOVA, considering the following factors: strain and treatment. 
 
OXY Hybridization in the PVN of PPAR-! -/-  and wild type mice  
The results are shown in Figure 6, (panel C and panel G). The two-way ANOVA 
of integrated optical density in the PVN of PPAR-!-/-  and wild type mice revealed 
the following results:  
F (strain) = 0.263, df = 1 / 69, n.s.  
F (treatment) = 4.638, df = 1 / 69, p <0.05  
F (strain x treatment) = 2,313 df = 1 / 69, n.s.  
The multiple comparisons performed by Tukey’s test showed that OEA admini-
stration produces a statistically significant increase of integrated optical density in 
the PVN of wild type mice (p <0.05, panel C), while no alteration has been ob-
served in PPAR-!-/-  mice (panel G). 
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OXY Hybridization in the SO of PPAR-! -/-  and wild type mice  
The results are shown in Figure 6, (panel D and panel H). The two-way ANOVA 
of integrated optical density in the SO of PPAR-!-/-  and wild type mice revealed 
the following results:  
F (strain) = 0.001, df = 1 / 66, n.s.  
F (treatment) = 2.845, df = 1 / 66, n.s 
F (strain x treatment) = 0.535 df = 1 / 66, p <0.05 
The multiple comparisons performed by Tukey’s test showed that OEA admini-
stration produces a statistically significant increase of integrated optical density in 
the SO of wild type mice (p <0.05, panel D), while no alteration has been ob-
served in PPAR-!-/-  mice (panel H). 
 
Feeding behavior analysis 
The results are shown in Figure 7. The statistical analysis of 18-hour cumulative 
food intake provided the following results: F = 6,093, df = 3 / 31, p <0.01. The 
multiple comparison test showed that OEA significantly inhibited food consump-
tion in rats (p <0.01), while the administration of atosiban 30 minutes before 
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OEA, completely reverted its effects, without producing per se any alteration of 
cumulative food intake. 
OEA treatment did not affect drinking or food access (data not shown). 
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DISCUSSION  
A large body of evidence indicate that the anorexiant effects of OEA are mediated 
by the activation of peripheral PPAR-alpha receptors, but the central mechanisms 
downstream to this activation are still unclear. Brain regions that area activated in 
rats after OEA treatment have been mapped on the basis of neuronal expression 
of c-fos mRNA, a mRNA product of the early response gene c-fos. OEA treat-
ment increased mRNA c-fos expression in two important hypothalamic nuclei in-
volved in the energy balance: the paraventricular nucleus (PVN) and the sopraop-
tic nucleus (SO) (Rodriguez de Fonseca et al., 2001). In agreement with these 
previous observations we found an increase of c-fos mRNA in both nuclei that is 
evident 30 min after OEA systemic administration, but reaches its maximum at 60 
min, decreasing at 120 and 240 minutes (data not shown).  The magnocellular 
components of both nuclei release oxy and avp, two of the anorectic hypotha-
lamic neuropeptides and project their axons to the posterior pituitary where they 
secrete oxy and avp into the periphery. Dendritic oxy acts locally to facilitate oxy 
neuron activity but also diffuse to distant sites as the amygdala. Smaller oxy neu-
rons of the PVN project centrally to various hypothalamic, limbic and brainstem 
regions. So central oxy system can provide a multi-level controlling influence on 
other brain regions and has an important role in the regulatory neuronal network 
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mediating satiety. Our hypothesis was that the increased c-fos mRNA in the PVN 
and SON might be paralleled by increase of oxy mRNA levels in the same neu-
rons. To test such hypothesis we performed a time-course and a dose response 
study in rats, systemically administered with OEA. We found that OEA treatment 
does cause an increase of oxy mRNA in the PVN and SO nuclei, and such in-
crease is highest at 60 minutes after treatment and is maximal at the dose of 10 
mg kg-1. The lack of effects at the highest dose of OEA (20 mg kg-1) is accompa-
nied by the lack of behavioral selectivity of the drug at this dose. In fact, while no 
effects of OEA on motor behavior and drinking activity are observed at both 5 
and 10 mg doses, a slight motor inhibition and a decrease of water consumption 
can be observed in rats treated with the highest dose of the compound (Rodriguez 
de Fonseca et al., 2001). We therefore, hypothesize that at this dosage other neu-
ronal signals might be modulated that could differently affect oxy mRNA levels 
in the PVN and SO. OEA effects on oxy mRNA appears highly selective, as we 
did not detect any alteration of avp mRNA in the same brain regions where the 
increase of oxy mRNA was observed. Moreover, by dual in situ hybridization we 
verified that OEA causes an increase of oxy mRNA expression in the same neu-
rons expressing higher levels of c-fos mRNA, thus suggesting that the activation 
of these neurons is accompanied to increased oxytocinergic tone.  
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Although OEA may bind to multiple receptors (Ahern et al., 2003; Overton et al., 
2006), different lines of evidence indicate that PPAR-! mediates the effects of 
this compound on energy homeostasis (Fu et al., 2003). PPAR-! knockout mice 
do not respond to OEA or synthetic PPAR-! agonists (Fu et al., 2003). Long-
term OEA administration causes metabolic changes similar to those produced by 
PPAR-! agonists, consisting of decreased serum cholesterol and triglyceride lev-
els in genetically obese rats (Fu et al., 2005). PPAR-! receptors are expressed 
also in the central nervous system, however some indications suggest that the 
anorexiant effect of OEA is mainly peripheral. In fact, OEA does not affect food 
intake when injected into the rat brain ventricles, and its anorexic actions are pre-
vented when peripheral sensory fibers are removed (Rodriguez de Fonseca, et al., 
2001). Interestingly, we found that a significantly increase of oxy mRNA in the 
PVN and SO nuclei can be observed in wild-type mice treated with OEA, 
whereas any alteration of oxy mRNA levels can be detected in PPAR-alpha-/- 
mice, following OEA administration. These observation highlight the correlation 
between oxy mRNA increase in the hypothalamus and the anorexiant effects of 
OEA, since they are both absent in PPAR-alpha-/- mice.  
To further test the occurrence of any relationship between oxytocinergic signal-
ling and the inhibition of food intake induced by OEA administration, we tested 
whether the oxy antagonist atosiban could block OEA effects on feeding. The re-
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sults of the behavioral experiment in rats confirmed our hypothesis, showing how 
a systemic dose of atosiban that per se does not produce any effect on feeding, 
can completely reverse the effects of OEA when it is pre-administered to rats re-
ceiving OEA. 
Similar findings on food intake and oxy involvement in the hypothalamus were 
observed also in the case of the anorexiant action of the CB1 antagonist rimona-
bant (SR141716A) (Verty et al., 2004). The study by Verty suggested an inter-
play between the endocannabinoid system and the oxytocinergic system in the 
hypothalamus. In fact, rimonabant and oxy administration in the hypothalamus 
were found to synergictically interact in reducing eating and CB1 receptor signal-
ing resulted necessary to prevent oxy from altering food intake. 
As mentioned before, OEA does not activate CB1 receptors, nor it can be consid-
ered an endocannabinoid, since its actions in vivo are drastically different from 
those produced by cannabinoid agonists. However, OEA can be synthetized and 
released, as well as hydrolyzed, together with anandamide, since they share sev-
eral metabolic pathways. Anandamide has opposite effects on feeding behavior, 
as, similarly to THC and other cannabinomimetic compounds, it can stimulate 
food intake.  
Rimonabant shares with OEA several effects on energy balance and food intake. 
However, although rimonabant acts on eating behavior predominantly blocking 
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central CB1 receptors, the actions of OEA on feeding are mostly peripheral. This 
difference is of crucial importance since the central effects of CB1 blockade are 
also responsible for the psychiatric side effects of rimonabant that caused its 
withdrawal from the market.  
OEA effects on oxy release in the PVN and SO are likely due to indirect activa-
tion on the hypothalamic nuclei, as suggested by previous findings showing an 
increase of c-fos mRNA in the NTS after OEA administration (Rodriguez de 
Fonseca et al., 2001). Thus, OEA might represent a novel pharmacological tool 
that simulates the effects of rimonabant on energy homeostasis, without blocking 
CB1 receptors directly but probably counterbalancing the effects of endogenous 
anandamide. Oxy release in the PVN and SO might represent one of the possible 
common target where such balance occurs and that is involved in the effects on 
feeding.  
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CHAPTER IV 
 
OEA AND BEHAVIOURAL SEQUENCY OF SATIETY 
 
 
INTRODUCTION: 
A plethora of drugs exist that inhibit food intake when administered to experi-
mental animals. One of the most contentious issues in the psychopharmacology of 
appetite concerns the identification of mechanism underlying an observed reduc-
tion of eating. It cannot be denied that many chemicals could suppress eating by 
producing adverse physiological effects such as pain, or illness, or by altering 
neurochemical systems or behavioral dispositions so as to prevent the normal e-
xpression of appetite. Because animals cannot report their aversive side effects to 
the experimenter, the maintenance of a normal structure in strings of behavioral 
acts may be used as a means  of verifying normal physiology. For over 20 years 
researchers have argued that the structure of behavior can be used as a marker of 
the nonphysiological effects of drugs on food intake. The utility of the behaviou-
ral sequence of satiety (BSS) rests initially on the validity of behavior as an indi-
cator of toxic, pathologic, or nonphysiological events. Monitoring animal beha-
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vior, inducing feeding, and nonfeeding activities could provide a powerful biobe-
havioral assay of drug action on appetite. Using this biobehavioral assay of fee-
ding avoids problems of model validity, as it does not rely on modeling the hu-
man condition, but uses the animal’s natural behavioral register as the yardstick 
of relevance (Halford et al., 1998). 
The commonest dependent variable recorded in animal studies aimed at under-
standing drug effects on feeding is amount of food eaten by the subjects. Food in-
take is the result of the interplay between internal and external variables (Ber-
thoud et al., 2002) and therefore, per se, not helpful to explain the mechanism af-
fecting food consumption. It has been suggested that important information on the 
action of compounds inducing changes in appetite can be obtained through a mo-
re detailed analysis of feeding behavior. In rodents, the BSS represents the natural 
progression from eating to resting, through active grooming, in its formal and o-
perational definition (Antin et al., 1975). 
Cannabinoid CB1 inverse agonist such as rimonabant SR141716A (Rinaldi et al., 
1994) hold therapeutic promise as appetite suppressants, but the extent to which 
non-motivational factors contribute to their anorectic effects is not fully known. 
Examination of the BSS in rats, the orderly progression from eating to post-
prandial grooming and then resting, has revealed that this compounds preserves 
the order of events but differ markedly from natural satiation . The most notable 
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difference is that grooming (particularly scratching) is profoundly enhanced at 
anoretic doses, while eating and resting are diminished, raising the possibility that 
anorectic effect is simply secondary to the grooming effect (Hodge et al., 2008).  
Acomplia is a medicine containing the active substance rimonabant. Acomplia 
was authorised in the European Union since June 2006 and was marketed in 18 
EU Member States. Rimonabant was also authorised as Zimulti, but this product 
was not marketed in the EU. Acomplia can cause psychiatric side effects, espe-
cially depression, since its initial assessment. Because patients at an elevated risk 
of developing psychiatric disorders could not be identified, the Committee con-
cluded that introducing further restrictions to the use of the medicine would be 
unlikely to reduce the risk to an acceptable level. Therefore, the Committee con-
cluded that the benefits of Acomplia no longer outweigh its risks, and recommen-
ded that the marketing authorisation for the medicine should be suspended across 
the EU (EMEA London 23 October). 
In this scenario, several researcher are actually focusing on the development of 
novel CB1 antagonists that could not cross the blood brain barrier, thus avoiding 
the central effects displayed by rimonabant and possibly responsible of the adver-
se side effects. Although several metabolic positive effects of accomplia are rale-
ted to CB1 antagonism at the periphery, the main effects on food intake appears 
to be centrally mediated. Thus, the question arises to whether a novel CB1 anta-
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gonist that cannot block central CB1 receptors might still modulate eating beha-
vior in laboratory animals as well as in humans. In this respect OEA might repre-
sent a better candidate for the development of novel therapeutic tools for obesity 
and over-eating. In fact, the effects of OEA appear to be mostly peripheral, while 
clearly influencing feeding behavior. 
In this study we compared the behavioral effects of OEA to those of rimonabant 
in mice subjected to the analysis of BSS. 
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METHODS 
Animals and experimental conditions 
Animals were housed under controlled 12-h light–dark cycle (7:00 A.M.–7:00 
P.M.), and allowed free access to food and water in their home cage. The basic 
diet consisted of standard laboratory dry food pellets (Mucedola s.r.l.). All ex-
periments took place during the dark cicle in a soundproof enviroment. Thirty-
eight male (C57/Bl6) mice were used for the study. The animals, weighing 
28±0.5 g on arrival, were purchased at approximately 10 weeks of age from Char-
les River (Como, Italy). All animals used were maintained in accordance with the 
regulations of the European Communities Council Directive (86/EEC) and ap-
proved by the Italian Government (Coccurello et al., 2008). 
Treatments 
Oleyolethanolamide (OEA) was synthesized in the laboratory (Giuffrida et al., 
2000), dissolved in saline/polyethylene glycol/Tween 80 (90/5/5, v/v; 2 ml Kg-1) 
and administered, 10 min before dark onset, by intraperitoneal (i.p.) injection at 
dose of 5 and 10 mg Kg-1  to free-feeding mice. Rimonabant (SR141716A), dis-
solved in the same vehicle of OEA, was administered (i.p.) at the same doses (5 
and 10 mg Kg-1 )  to free-feeding mice. Control animals received an i.p. injection 
of vehicle. 
  
87 
 
Experimental procedure 
Before starting the pharmacological study, mice were habituated to a semi-liquid 
diet (wet mash). The diet was made up of a mix of one part ground standard dry 
powdered food pellets and water (Coccurello et al., 2008). Furthermore, the con-
sistency of mash virtually eliminates spillage and prevents animals from remov-
ing food to hoard or eat elsewhere (Halford et al., 1998). The food pot, weighed 
immediately prior testing, was positionated in the opposite side of the bottle of 
water in the cage. To familiarize the animals to the new diet, fresh meals were 
prepared and offered for one week before administration of OEA and 
SR141716A. The experimental phase started at the end of final habituation trials 
and was conducted according to a within-subjects (crossover) design. The treat-
ment condition was determined by Latin Square. One hour before each recording 
session, mice were food deprived while water remained available. To analyze 
feeding behavior, subjects were individually placed in a new test cage strewn with 
the home cage bedding and freely allowed to access the diet up to 45 min. Each 
food container was preweighed, and the difference between initial and final food 
container weights was the measure of wet mash intake. 
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Behavioral satiety sequence analysis 
Data were collected between 19:00 and 20:00 p.m. in a soundproof cubicle 
equipped with a video-recording camera. Test DVDs recorded were scored blind 
by a highly trained observer using software OBSERVER. 
After presentation of wet mash, the behavioural sequence was recorded by ob-
serving each mouse for 45 min and allocating its current behaviour to one of five 
categories. The behavioural categories were: ‘duration of eating’: holding or in-
gesting of food; ‘active’: moving, rearing and other behaviour patterns not de-
fined elsewhere; ‘groom’: body care movements using mouth or forelimbs; and 
‘inactive’: characterized as an absence of movement with a resting posture, with 
or without eye closure (Somerville et al., 2007). ‘Eating latency’: time to begin 
eating measured from initial contact with food. 
Data analysis 
One way ANOVA was used to analyze duration of eating of observed behavior 
with drugs (2 different doses) during the 45 min test session, multiple comparison 
were performed by Tukey’s post hoc test. In all instances, statistical significance 
threshold was set at p<0.0001.  
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RESULTS AND DISCUSSION  
Analysis of the behavioral patterns over the course of the 45 min session showed 
a significant decrease in eating time of the 5 mg/kg and 10 mg/kg OEA group in 
comparison to vehicle mice (Figure 1 panel A, B and C). Eating time decrease 
was similar to 5 mg/kg and 10 mg/kg SR141716A group in comparison to vehicle 
mice (Figure 2 panel A, B and C).  
Food intake was significantly affected by drug treatment: the one-way ANOVA 
revealed the following results: F=9.723; df= 4 / 36; p<0.0001  
The multiple comparisons performed by Tukey’s post hoc test showed that the 
treatment with OEA 5 mg/kg and OEA 10 mg/kg produced a statistically signifi-
cant decrease in eating time (respectively p <0.01 and p< 0.001 vs vehicle). Also 
SR171416A 5 mg/kg and 10 mg/kg confirmed a statistically significant decrease 
in eating time respectively p<0.001 and p<0.001 vs vehicle; no differences in the 
amount of the food eaten were found between 5 mg/kg and 10 mg/kg of OEA or 
SR141716A administered mice (Figure 3). 
The BSS has been extensively used to characterize the influence of pharmacol-
ogical and non pharmacological manipulation on the normal pattern of behaviours 
associated with feeding ( Halford et al., 1998). Throughout its study it is possible 
to accurately monitor the development and the behavioural structure of the satia-
tion process. Indeed, in basal conditions, the ingestion of food gradually induces 
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satiation, a process demonstrated by the replacement of feeding with other non-
feeding activities (such as grooming), ending in a long-lasting resting period 
(Coccurello et al., 2008). To our knowledge, this is the first study analyzing the 
structure of BSS after OEA administration.  
OEA caused a marked increased of the latency to the first food approach. This ef-
fect was similar to those produced by rimonabant and is in accordance with pre-
vious studies (Gaetani et al., 2003). Interestingly, while OEA did not affect 
grooming behaviour, rimonabant caused an increase of it, as previously reported. 
On the other hand, the decrease of food intake elicited by OEA and rimonabant 
was similar, thus suggesting that OEA might simulate the positive effects of Ri-
monabant on feeding, avoiding its ambiguous effects on other aspects of animal 
behaviour that might be predictive of adverse side effects in humans. 
We, theefore suggest that OEA might represent a valid alternative approach to pe-
ripherally acting novel CB1 antagonists. 
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